Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
Taiwan · Delayed Price · Currency is TWD 57.00
+0.50 (0.88%)
May 29, 2026, 1:30 PM CST
TPEX:4747 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 98.23 | 53.51 | 84.12 | 79.7 | 64.85 | 49.1 |
Depreciation & Amortization | 20.22 | 20.34 | 20.97 | 21.11 | 18.27 | 15.29 |
Loss (Gain) From Sale of Assets | - | 0.08 | - | -0.01 | - | 0.01 |
Loss (Gain) From Sale of Investments | -69.49 | -13.77 | 0.44 | -0.15 | - | - |
Stock-Based Compensation | - | - | - | 6.38 | - | - |
Provision & Write-off of Bad Debts | 0.58 | -0.23 | -0.2 | 0.09 | 0.88 | - |
Other Operating Activities | 24.61 | 27.62 | -7.77 | 8.13 | 3.42 | 4.97 |
Change in Accounts Receivable | -16.44 | 3.55 | -2.2 | -4.87 | -23.76 | -2.49 |
Change in Inventory | -67.36 | -47.57 | -2.09 | -11.78 | 19.45 | 11.44 |
Change in Accounts Payable | 28.99 | 18.65 | -27.87 | 34.5 | -1.67 | -17.03 |
Change in Unearned Revenue | 7.17 | -1.71 | 0.52 | 0.29 | -1.33 | 3.51 |
Change in Other Net Operating Assets | -12.56 | 11.23 | -3.04 | 3.56 | 9.58 | -12.46 |
Operating Cash Flow | 13.96 | 71.71 | 62.88 | 136.95 | 89.69 | 52.35 |
Operating Cash Flow Growth | -83.33% | 14.04% | -54.09% | 52.70% | 71.33% | -27.07% |
Capital Expenditures | -63.72 | -64.05 | -13.19 | -33.12 | -59.71 | -37.29 |
Sale of Property, Plant & Equipment | - | - | - | 0.01 | - | - |
Cash Acquisitions | -913.26 | - | - | - | - | - |
Investment in Securities | -88.61 | -88.61 | - | - | - | - |
Other Investing Activities | -1.36 | -1.11 | 0.24 | -0.17 | -0.21 | -0.86 |
Investing Cash Flow | -1,067 | -153.76 | -12.96 | -33.28 | -59.92 | -38.15 |
Short-Term Debt Issued | - | 140 | - | - | - | - |
Long-Term Debt Issued | - | - | - | 395.36 | - | - |
Total Debt Issued | 1,060 | 140 | - | 395.36 | - | - |
Short-Term Debt Repaid | - | - | - | - | -20 | -50 |
Total Debt Repaid | - | - | - | - | -20 | -50 |
Net Debt Issued (Repaid) | 1,060 | 140 | - | 395.36 | -20 | -50 |
Issuance of Common Stock | - | - | - | 480 | - | - |
Common Dividends Paid | -78.63 | -78.63 | -67.32 | -60.04 | -43.53 | -57.64 |
Other Financing Activities | - | 0.16 | -0.15 | 0.15 | - | - |
Financing Cash Flow | 981.37 | 61.53 | -67.47 | 815.47 | -63.53 | -107.64 |
Net Cash Flow | -71.62 | -20.53 | -17.55 | 919.14 | -33.76 | -93.44 |
Free Cash Flow | -49.76 | 7.66 | 49.68 | 103.84 | 29.98 | 15.06 |
Free Cash Flow Growth | - | -84.58% | -52.15% | 246.36% | 99.09% | - |
Free Cash Flow Margin | -8.74% | 1.34% | 8.13% | 17.11% | 6.06% | 3.66% |
Free Cash Flow Per Share | -0.97 | 0.16 | 1.07 | 2.73 | 1.00 | 0.50 |
Cash Interest Paid | 1.95 | 1.95 | 1.54 | 1.42 | 1.06 | 1.2 |
Cash Income Tax Paid | 21.57 | 21.57 | 34.33 | 16.23 | 13.27 | 7.74 |
Levered Free Cash Flow | -12.51 | -26.89 | 22.48 | 80.62 | 15.88 | 9.92 |
Unlevered Free Cash Flow | -8.14 | -24.55 | 24.67 | 83.49 | 16.54 | 10.59 |
Change in Working Capital | -60.2 | -15.85 | -34.68 | 21.7 | 2.27 | -17.02 |